Life Sciences & Medicine Active Updated Nov 11, 2026
A clot-stopping stroke drug that spares the bleeding
Where it stands as of Nov 11, 2026
The FDA has approved Bayer's Sunharbo, the first of the factor XIa inhibitor class, to prevent recurrent stroke, which hits roughly 20% of stroke survivors. The drug is meant to prevent clots without raising bleeding risk. How it performs in everyday use, beyond the trials behind the approval, is not yet known.
The story so far
-
Nov 11, 2026 Latest
STAT reported that the FDA approved Bayer's Sunharbo, the first of a new class of drugs meant to prevent clots without raising bleeding risk, for the roughly 20% of stroke survivors who have a second stroke.
This story moves with the morning letter.
When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.
Free for good. One click to leave.